|Videos|December 20, 2022

Expert Perspectives on Novel Drug Delivery Systems in the Management of Pediatric ADHD

Author(s)Jeffrey L Alvaro, MD

Jeffrey L. Alvaro, M.D., introduces an upcoming panel discussion surrounding the clinical implications of novel drug delivery systems in the management of Pediatric ADHD, utilizing 3 patient cases.

Episodes in this series

EP. 1 Expert Perspectives on Novel Drug Delivery Systems in the Management of Pediatric ADHD

EP. 1 Expert Perspectives on Novel Drug Delivery Systems in the Management of Pediatric ADHD

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Collaborative care program increases pediatricians’ confidence in managing pediatric mental health

Collaborative care program increases pediatricians’ confidence in managing pediatric mental health

ByJohn T. Parkhurst, PhD

August 6th 2026

CTx-1301 improves pediatric ADHD symptoms in phase 3 trial | Image Credit: © Tiara - stock.adobe.com.

CTx-1301 improves pediatric ADHD symptoms in phase 3 trial

ByContemporary Pediatrics Staff

July 30th 2026

FDA approves centanafadine for ADHD in children, adolescents, and adults

FDA approves centanafadine for ADHD in children, adolescents, and adults

ByMorgan Ebert, Executive Editor

July 27th 2026

Later ADHD diagnosis linked to worse educational outcomes | Image Credit: © NDABCREATIVITY - © NDABCREATIVITY - stock.adobe.com.

Later ADHD diagnosis linked to worse educational outcomes

ByCeleste Krewson, Assistant Editor

April 8th 2026

Rebecca Chasnovitz, MD, highlights updates in pediatric ADHD medication | Image Credit: unchealth.org.

Rebecca Chasnovitz, MD, highlights updates in pediatric ADHD medication

ByRebecca Chasnovitz, MD

February 24th 2026

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Contemporary Pediatrics

FAQ: What does the new AAP iron deficiency guidance mean for your practice?

CDC declares Nara Organics infant botulism outbreak over as genetic testing links it to 2025 ByHeart outbreak

New multisociety position paper details hospital strategies to close gaps in sepsis care

Contemporary Pediatrics week in review: August 24-28, 2026

Longer treatment may yield continued improvement in pediatric anxiety